PubMed چکیده/رکورد

Hematologic Malignancies in Critical Care: A National Observational Comparison Between ICU and Non-ICU Patients.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

PURPOSE: Critically ill patients with hematologic malignant (HM) diseases are a heterogeneous but vulnerable group, where intensive care (ICU) is associated with high mortality. The impact of ICU care on long-term survival is less well described. This retrospective national cohort study investigates the long-term survival outcomes of hospitalized HM patients, comparing ICU survivors with non-ICU patients. In addition, focused analyses were performed on the ICU cohort to further investigate survival patterns. METHODS: Adult patients diagnosed with HM and admitted to hospital between May 6, 2014, and December 31, 2019, were identified through the National Patient Registry. ICU admissions from these patients were obtained from the Norwegian Intensive Care and Pandemic Registry. Survival was measured from the time of first diagnosis until death or December 31, 2020. The patients were divided into three diagnostic groups: lymphoma, chronic leukemia, myeloma and acute leukemia. RESULTS: Among 26,281 hospitalized patients with HM, 2094 required ICU care. Long-term survival from diagnosis to end of follow up varied significantly by ICU status. Compared with patients who never required ICU, mortality rose sharply during ICU care (HR 148; 95% CI 133-165) and remained elevated after discharge (HR 4.47; 95% CI 4.42-5.07). Acute leukemia was identified as a strong risk factor (HR 4.27; 95% CI 3.99-4.56). In the focused ICU cohort analyses, ICU survival was 81%, and one-year post-ICU survival was 45%. Acute leukemia and elevated SAPS II score, but not allogeneic transplant status, independently predicted ICU mortality. CONCLUSION: While most HM patients survive ICU admission, long-term survival is decreased compared with non-ICU patients. EDITORIAL COMMENT: This analysis of hematological malignancy cases in Norway presents and compares outcomes for those in the subgroup requiring intensive care treatment, compared to those not requiring care in the intensive care unit. Intensive care unit survival was high, but severity of illness in the ICU was associated with worse long-term survival.

متن کامل اصلی

متن در JumpToDate ذخیره نشده است.

برای بررسی دسترسی کتابخانه‌ای یا خرید، رکورد اصلی را باز کنید.

رفتن به منبع اصلی

کلیدواژه‌ها

critical carehematologic malignancyintensive caremortalityoutcome
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2026

Comparison of the Validity and Reliability of Five Pressure Injury Risk Scales in Intensive Care.

BACKGROUND: The lack of consensus on the best pressure injury (PI) risk assessment tools demonstrates the need for further comparative research to identify the most effective options for intensive care unit (ICU) populations. AIM: This study compared the predictive validity and reliability of five PI risk assessment tools in adult ICU patients. STUDY DESIGN: A prospective cohort study was conducted with patients aged ≥ 18 years, admitt…

PubMed2026

Cross-Sectional Survey of Critical Care Provision in Ministry of Health Hospitals in Zambia.

BACKGROUND: Critical care is an essential component of universal health care; however, its provision in low- and middle-income countries remains poorly understood. Although Zambia has expanded critical care services over the last 15 years, national evidence regarding workforce capacity, infrastructure and service provision remains limited. AIMS: To evaluate critical care workforce, service provision and patient case mix across Ministry…

PubMed2026

Electronic Patient-Reported Health-Related Quality of Life Trajectories in ICU Survivors: A Multicentre Pilot Study-Within-a-Trial Protocol.

BACKGROUND: Patient-important outcomes beyond mortality, particularly health-related quality of life (HRQoL), are frequently used in intensive care unit (ICU) trials. However, HRQoL assessment remains challenging due to methodological complexities, including poorly defined recovery trajectories, lack of consensus on measurement instruments, complexity of statistical analysis, and missing data. Electronic patient-reported outcomes (ePRO…

PubMed2026

Evaluating Meaningful Patient and Public Involvement in Intensive Care Research-A PEIRS-22 Survey.

BACKGROUND: Patient and public involvement (PPI) is increasingly recommended in health research to enhance relevance, quality and implementation of findings. In intensive care research, involving patients, family members and healthcare professionals may help ensure that research addresses outcomes that are meaningful to those affected by critical illness. AIM: This study aimed to assess the level of meaningful PPI engagement during the…